Natco Pharma share news, announcements and annual reports
NSE: NATCOPHARMBSE: 524816Pharmaceuticals & BiotechnologySmall Cap
Natco Pharma Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 1995 on BSE, Dec 1995 on NSE
Last close ₹782.40down ₹5.15 (0.65%)BSE ₹782.50
Share price at the NSE close on 30 Oct 2026. Previous close ₹787.55.
30 Oct: open ₹792.05, high ₹800.90, low ₹779.50
52-week range of traded prices to 30 Oct 2026
₹773.60Low, 22 Oct 2026₹1,226.80High, 12 May 2026
- Next results date: the board meets on 13 Nov 2026 to consider: financial results and dividend. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15,348 Cr380th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 13.41
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.58%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 8.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.08
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,21,54744.0% delivered
Natco Pharma share news and announcements
1,035 announcements, routine notices left out, newest first. Page 19 of 21.
Jun 2009
30 Jun · Press Note
Press note dated June 30, 2009, titled "NATCO records higher sales, profits". A copy of the press note shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.18 Jun · Board meeting
To consider among other things the Audit Results for the Financial year ended March 31, 2009 and related matters.
May 2009
25 May · Dividend
Vide its letter dated May 25, 2009 that "The Board of Directors at their meeting held on today declared an interim dividend of Rs.1.25 per share for the year 2008-09. The date fixed for taking a record of its shareholders eligible for the purpose of payment of interim dividend is 5th June, 2009 i.e. record date".14 May · Board meeting
To consider among other things, consideration of declaration of Interim Dividend, if any, for the Financial Year 2008-2009 and related matters.
Apr 2009
15 Apr · Business
Press release dated April 15, 2009, titled "NATCO ties up with Dr. Reddy's for oncological products". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.13 Apr · Results
Company will be considering the Audited Results for the quarter ending March 31, 2009 instead of Un-audited results. Audited Results for the quarter ending March 31, 2009 will be announced on or before June 30, 2009 .9 Apr · Business
Press release dated April 09, 2009, titled "NATCO joins hands with LUPIN to commercialize Lanthanum Carbonate tablets, possibility of being first filers". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Mar 2009
17 Mar · Updates
We have received an intimation from Time Cap Pharma Labs Pvt Limited, a Person Acting in Concert of the company that the name of Time Cap Pharma Labs Pvt Ltd has been changed to Time Cap Pharma Labs Limited16 Mar · Business
Press release dated March 16, 2009, titled "NATCO Successfully Opposes Indian Patent Application Covering Composition of Teva's Copaxone(R) Multiple Sclerosis Treatment". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2009
10 Feb · Disclosure
Disclosure under Regulation 8A (4) of Securities and Exchange Board of India (Substantial Acquisition of Shares & Takeovers) (Amendment) Regulations, 2009, in respect of pledge of 10,50,000 equity shares of Rs. 10/- each by one of the Promoters of the Company, out of his total holding of 78,84,459 equity shares of Rs. 10/- each held by him in the Company. This pledge represents 3.74% of the Company's outstanding shares as on February 10, 2009. The Total Promoters holding in the Company is 61.39% of the Company's outstanding shares. A copy of the disclosure shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2009
27 Jan · Business
Press release dated Janaury 27, 2009, titled "Natco's Q3 results". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.15 Jan · Board meeting
To consider among other things, the Un-audited financial results (Provisional) for the quarter ended December 31, 2008.
Nov 2008
4 Nov · Updates
"Natco records jump in earnings, profits". The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2008
20 Oct · Board meeting
To consider among other things, the Un-audited financial results (Provisional) for the quarter ended September 30, 2008.
Sep 2008
26 Sep · Meeting
Members of the company at their Annual General Meeting for the financial year 2007-08 held on September 26, 2008 have passed the follwing Resolutions. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.19 Sep · Business
Press release dated September 19, 2008, titled "Natco makes a debut in nano-technology, launches Albupax". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2008
31 Jul · Meeting
Annual General Meeting of the members of the Company will be held on September 26, 2008. Further, the Register of Members and Transfer books of the Company will remain closed for three days from September 24, 2008 to September 26, 2008 (both days inclusive).31 Jul · Business
Press release dated July 31, 2008, titled "Natco's Q1 results". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.21 Jul · Board meeting
To consider among other things, the Unaudited financial Results for the quarter ended June 30, 2008 and convening of Annual General Meeting and related matters etc.
Jun 2008
30 Jun · Updates
Natco's revenues, profits grow over 30%. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.17 Jun · Board meeting
To consider among other things, the Audited Results for the financial year ended March 31, 2008, audited accounts for the year 2007-08 and related matters.10 Jun · Press Note
Press note dated June 10, 2008, titled "NATCO collaborates with Mylan for Glatiramer Acetate". A copy of the press note shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2008
12 May · Press Note
Press note dated May 12, 2008, titled "Natco Pharma bags Technology Development Board Award". A copy of the press note shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2008
16 Apr · Results
The Company will be considering the Audited Results for the quarter ending 31st March, 2008 instead of Un-audited Results. Audited Results for the quarter ending 31st March, 2008 will be announced on or before 30th June, 2008
Mar 2008
19 Mar · Press Note
Press note dated March 19, 2008 which is as follows: "The Hyderabad based NATCO Pharma's API facility situated at Mekaguda village, in Mahaboobnagar District, Andhra Pradesh (which is already approved by the US FDA) has just completed, successfully, an inspection by US FDA for approval of the following additional products : a) Imatinib Mesylate - medicine for blood cancer; b) Anastrazole - medicine for breast cancer; c) Granisetron - treatment for nausea d) Rizatriptan - for the treatment of migrane. With these approvals in place, NATCO remains a preferred source of supply for multinational companies around the world".
Feb 2008
6 Feb · Press Note
Press note dated February 06, 2008, titled "NATCO acquires Newark Drugs". A copy of the press note shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2008
25 Jan · Allotment of shares/ others
Board of Directors at their meeting held on January 25, 2008 has allotted 1,04,475 equity shares of Rs.10/- each to employees of the Company which includes 5,000 shares to non-promoter directors and 2,500 shares for non-promoter working director under stock option scheme (grant price Rs.10/- per option). Further the Company has submitted a copy of Press note dated January 25, 2008, titled "Natco Pharma records higher revenues and increased profits". A copy of the press note shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.21 Jan · Board meeting
To consider among other things, the unaudited financial results (Provisional) for the quarter ended December 31, 2007 and related matters.14 Jan · Updates
Hyderabad based Natco Pharma Limited had bagged the Patents Appreciation Award for the year 2006-2007 instituted by the Indian Drug Manufacturers association (IDMA). The award was presented to the Company at a glittering ceremony held at Mumbai on Friday, the 11th January, 2008. NATCO continues to be occupy the second position among the pharmaceutical companies from South India who have filed the largest number of applications for patents. This is second time that NATCO has bagged this award from IDMA11 Jan · Press Note
Press note dated January 11, 2008, titled "NATCO's drug gets Canadian approval". A copy of the press note shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Dec 2007
6 Dec · Press Note
Press note dated December 06, 2007, titled "NATCO launches XTANE". A copy of the press note shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2007
16 Nov · Allotment of Equity Shares
Vide its letter dated November 16, 2007, that: "The Committee constituted for the issue of Foreign Currency Convertible Bonds (FCCBs) and related matters at its meeting held on today allotted 4,66,584 equity shares of Rs.10/- each at a Conversion price of Rs.121/- per share. These shares were allotted consequent upon conversion of 143 numbers of 1.5% Unsecured Foreign Currency Convertible Bonds due in the year 2007 to the FCCB holders who had exercised their right of conversion of bonds into equity shares. The details are as follows: 1) Name of the Allottee - Rhodes Diversified; No. of shares - 4,66,584".
Oct 2007
26 Oct · Miscellaneous
Vide its letter dated October 25, 2007 that Hyderabad based NATCO Pharma Limited has recorded an increase of 30% in its revenues for the quarter ended September 30, 2007. The Company had clocked consolidated revenues of Rs.90.41 Crores during the quarter as against Rs.69.74 Crores in the same quarter last year. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.26 Oct · Dividend
Board of Directors at their meeting held on October 25, 2007 declared an interim dividend of Rs.1.25 ps. per share for the year 2007-08. The date fixed for taking a record of its shareholders eligible for the purpose of payment of interim dividend is November 13, 2007 i.e record date.16 Oct · Board meeting
To consider among other things, the unaudited financial results (Provisional) for the quarter ended September 30, 2007, consideration of declaration of Interim Dividend, if any, for the financial year 2007-2008 and related matters.1 Oct · Meeting
Members of the Company at their Annual General Meeting for the financial year 2006-07 held on September 29, 2007 have passed the resolutions. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2007
11 Sep · Press Note
Press note dated September 11, 2007, titled "Natco launches "LENALID"". A copy of the press note shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2007
7 Aug · Extinguishment
The company had extinguished 1,74,113 Equity shares of Rs.10/- each under the Buyback Scheme accepted during the period from 1st July to 31st July, 2007 by executing Corporate Action on July 12, 2007, July 28, 2007 & July 30, 2007 to debit 39000 & 80000 & 55113 securities respectively from the buyback account opened by the Company in the Central Depository Services (India) Limited. Consequent to the extinguishment of shares the paid up equity share capital of the Company stands reduced to 2,74,69,768 shares of Rs.10/- each2 Aug · Buyback of Shares
Buyback of equity shares by Natco Pharma Limited in terms of SEBI (Buyback of Securities) Regulation, 1998 as amended. The company has successfully completed and closed the buyback program on July 30, 2007. A copy of the Closure Ad published in the newspaper in this regard on August 01, 2007 shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2007
26 Jul · Press Note
Press note dated July 26, 2007, titled "Natco's Q1 results". The details of the press note shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.26 Jul · Meeting
Annual General Meeting of the members of the Company will be held on September 29, 2007. The Register of Members and Transfer books of the Company will remain closed for three days from September 27, 2007 to September 29, 2007 (both days inclusive).16 Jul · Board meeting
To consider among other things, the unaudited financial Results for the quarter ended June 30, 2007 and related matters.11 Jul · Press Note
Press note dated July 11, 2007, titled "NATCO acquires SaveMart Pharmacy". The details of the press note shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Jul · Extinguishment
The company had extinguished 1,53,118 Equity shares of Rs.10/- each under the Buyback Scheme accepted during the period from 1st June to 30th June, 2007 by executing Corporate Action on June 04, 2007 & June 27, 2007 to debit 57,000 & 96,118 securities respectively from the buyback account opened by the Company in the Central Depository Services (India) Limited. Consequent to the extinguishment of shares the paid up equity share capital of the Company stands reduced to 2,76,43,881 shares of Rs.10/- each
Jun 2007
26 Jun · Press Note
Press note dated June 26, 2007, titled "NATCO receives US FDA approval for Ondansetron; Ships out first consignment". The details of the press note shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.25 Jun · Buyback of Shares
Daily Report of Buyback of the Company's equity shares, the details of which are as follows: (1) Date of buyback: June 25, 2007; (2) No. of equity shares bought back on BSE - 7,000; (3) No. of equity shares bought back on NSE - Nil; (4) Total no. of equity shares bought back - 7,000; (5) Cumulative Equity Shares bought as on June 22, 2007 (includes quantity closed out as on 21/06/07) - 3,20,871; (6) Quantity closed out on June 25, 2007 - Nil; (7) Quantity Closed out as on June 22, 2007 - 2103; (8) Total Quantity Closed Out - 2103; (9) Total equity shares bought back as on June 25, 2007 - 3,25,768; (10) Average Price of acquisition - Rs.141.27/-.22 Jun · Buyback of Shares
Daily Report of Buyback of the Company's equity shares, the details of which are as follows: (1) Date of buyback: June 22, 2007; (2) No. of equity shares bought back on BSE - 4,118; (3) No. of equity shares bought back on NSE - Nil; (4) Total no. of equity shares bought back - 4,118; (5) Cumulative Equity Shares bought as on June 21, 2007 (includes quantity closed out as on 20/06/07) - 3,16,753; (6) Quantity closed out on June 22, 2007 - Nil; (7) Quantity Closed out as on June 21, 2007 - 2103; (8) Total Quantity Closed Out - 2103; (9) Total equity shares bought back as on June 22, 2007 - 3,18,768; (10) Average Price of acquisition - Rs.141.33/-.22 Jun · Press Note
Press note dated June 21, 2007, titled "NATCO announces launch of oral contraceptive- To fortify presence in Gynaecology segment". The details of the press note shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Jun · Buyback of Shares
Daily Report of Buyback of the Company's equity shares, the details of which are as follows: (1) Date of buyback: June 21, 2007; (2) No. of equity shares bought back on BSE - 7000; (3) No. of equity shares bought back on NSE - Nil; (4) Total no. of equity shares bought back - 7000; (5) Cumulative Equity Shares bought as on June 20, 2007 (includes quantity closed out as on 19/06/07) - 3,09,753; (6) Quantity closed out on June 21, 2007 - Nil; (7) Quantity Closed out as on June 20, 2007 - 2103; (8) Total Quantity Closed Out - 2103; (9) Total equity shares bought back as on June 21, 2007 - 3,14,650; (10) Average Price of acquisition - Rs.141.35/-.21 Jun · Buyback of Shares
Daily Report of Buyback of the Company's equity shares, the details of which are as follows: (1) Date of buyback: June 20, 2007; (2) No. of equity shares bought back on BSE - 7000; (3) No. of equity shares bought back on NSE - Nil; (4) Total no. of equity shares bought back - 7000; (5) Cumulative Equity Shares bought as on June 19, 2007 (includes quantity closed out as on 18/06/07) - 3,02,753; (6) Quantity closed out on June 20, 2007 - Nil; (7) Quantity Closed out as on June 19, 2007 - 2103; (8) Total Quantity Closed Out - 2103; (9) Total equity shares bought back as on June 20, 2007 - 3,07,650; (10) Average Price of acquisition - Rs.141.43/-.